New burn surgery approach aims to reduce bleeding without side effects
NCT ID NCT01731444
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a drug called phenylephrine can control bleeding during burn surgery as well as the standard drug epinephrine, but without causing unwanted changes in heart rate or blood pressure. About 24 adults with burns needing skin grafts will take part. The goal is to find a safer option for reducing blood loss during these procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD LOSS, SURGICAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Manitoba
RECRUITINGWinnipeg, Manitoba, R3A 1R9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A drug that may curb bleeding during fibroid surgery faces its first big test
- Which drug cuts C-Section bleeding best? tranexamic acid vs misoprostol put to the test
- Anesthesia choice may influence blood loss in hip fracture surgery
- Can a simple drug cut blood loss in kids with CP after hip surgery?
- Could a single drug replace the standard cocktail for C-Section bleeding?
- Simple drug may cut bleeding in broken leg surgery